Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 12.49MNet Cash Flow - Financing
VS
Market
Sector
Industry
History
$ 4.15Close
$ 4.15 - $ 16.1 52-Week Range
Ticker Information
Ticker
DRMACompany Name
DERMATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDERMATA THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DRMA - CF - Financing Historical data
| Date | Net Cash Flow - Financing |
|---|---|
| 6/30/2025 | $ 12.49M |
| 3/31/2025 | $ 15.38M |
| 12/31/2024 | $ 6.89M |
| 9/30/2024 | $ 8.91M |
| 6/30/2024 | $ 4.26M |
| 3/31/2024 | $ 3.43M |
| 12/31/2023 | $ 7.61M |
| 9/30/2023 | $ 5.65M |
| 6/30/2023 | $ 5.69M |
| 3/31/2023 | $ 8.45M |
Key Performance Insights, Last 5 Years
- DERMATA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 2.57M.
- Over the past 5 years, DERMATA THERAPEUTICS INC's average CF - Financing has been $ 8.68M.
- The median CF - Financing for DERMATA THERAPEUTICS INC during this period was $ 7.25M
- DERMATA THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 18.66M.
- The lowest CF - Financing recorded by DERMATA THERAPEUTICS INC in the same timeframe $ 2.57M
Similar metrics to CF - Financing:
- Net Cash Flow - Investing - [Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Net Cash Flow - Issuance (Repayment) of Debt Securities - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
Definition of Net Cash Flow - Financing
[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.DRMA - Net Cash Flow - Financing, Last 5 years
$ 2.57M
Minimum
Dec 31, 2020
$ 18.66M
Maximum
Jun 30, 2022
$ 8.68M
Average
$ 7.25M
Median
CF - Financing Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
| filtered constituents | 3.22K |
|---|---|
| min | $ -367.1M |
| max | $ 366M |
| average | $ -6.84M |
| median | $ 305K |
| std | $ 119.27M |